| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |